Get started

180 Life Sciences Corp.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals

ATNF chart

Key stats

Market capitalization
3.585MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−23.8328USD
Net income
−38.726MUSD
Revenue
—
Shares float
5.576M
Beta
1.17

About 180 Life Sciences Corp.

Sector
Health Technology
CEO
Jim N. Woody
Headquarters
Palo Alto
Website
180lifesciences.com
Employees
5
Founded
2016
ISIN
US68236V2034

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

Ideas

ATnF Had a pretty sweet uptrend here, something to watch as buyers have been strong. Previous reistance was at 4.88 areas to 4.86. We backtest that twice so far today and although 5$ was a reistance previously, it seems since we broke higher today it has now become an easy clearing level. The newest rei
Long
ATNF | Is My Math Off? | LONG1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is un
Long
2
could this be worth over $3? (ATNF)its not much of an uptrend, but the daily is enjoying a sizeable bounce so far, qnd im looking for this to continue into noon or maybe 1pm. the RHS i have mapped out was not obvious until this morning as we did not clearly break the downtrend with our right shoulder. normally this invalidates the pa
Long
1
Very good deal with High risk!!!The action picked up on a wave of news about the filing of medical approvals. Resistance ahead is 6.50. If it breaks through, there is a chance to go as high as 10.70 Upside:90%! ❤️ If you find this helpful and want more FREE forecasts in TradingView . . . . . Please show your support back, . . . .
Long
3
ATNF ReversalATNF has made higher lows since it gapped down in mid August. The price is still oversold with an RSI just under 50. The most recent candles have tested the 200MA and the .23 fib levels. Yesterday's candle made an inside bar which is a bullish signal in an uptrend. Looking for the price to move
Long
ATNF 180 Life Sciences Private PlacementATNF 180 Life Sciences Corp. received a Private Placement of $15.0 million for 2,500,000 shares of common stock at a combined purchase price of $6.00 per share and accompanying warrant at an exercise price of $7.50 per share and will expire five years from the date of issuance. I consider this 7.5u
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers